What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially announce Bristol-Myers Squibb's financial results for the first quarter of 2024, along with providing supporting documentation for investors.

Where can I find the detailed financial results for Q1 2024?

The detailed financial results are available in the Earnings Press Release (Exhibit 99.1), which is furnished as part of this 8-K filing and can also be found on the company's website. A presentation (Exhibit 99.2) is also available for further insights.

Does the report include non-GAAP financial measures?

Yes, both the Earnings Press Release and the Bristol Myers Presentation include references to non-GAAP financial information. The company provides reconciliations between these non-GAAP measures and the comparable GAAP measures within the Earnings Press Release.

Is the information in this filing considered 'filed' with the SEC for liability purposes?

No, according to General Instruction B.2. to Form 8-K, the information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities thereof, unless specifically incorporated by reference into future filings.

BMY 8-K: Earnings & Results & Regulation FD

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on April 25, 2024, primarily to announce its first quarter 2024 financial results. The filing includes a press release detailing these results and a presentation discussing financial and operational initiatives. Investors should note that both the press release and presentation contain non-GAAP financial information, with reconciliations provided in the press release. This report serves as a formal notification of the Q1 2024 performance and provides supplementary materials for a deeper understanding of the company's financial standing and strategic direction. The company has made these materials available on its website and through a webcast, allowing investors to access detailed financial data and management's commentary on the quarter's performance and outlook.

Key Highlights

1BMY announced its first quarter 2024 financial results on April 25, 2024.
2The company furnished an Earnings Press Release (Exhibit 99.1) detailing Q1 2024 financial performance.
3A Bristol Myers Presentation (Exhibit 99.2) was also posted on the company's website, covering financial and operating initiatives.
4Both the press release and presentation contain non-GAAP financial information.
5Reconciliations between non-GAAP and GAAP financial measures are available in the Earnings Press Release.
6The materials are provided in conjunction with a conference call and webcast for Q1 2024 results.
7The company noted that the furnished information is not deemed 'filed' for Section 18 purposes under the Exchange Act.

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Apr 25, 2024)

Summary

Key Highlights

Frequently Asked Questions